HEADER HYDROLASE/HYDROLASE INHIBITOR 21-NOV-12 4I1R
TITLE HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH THIORIDAZINE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION
COMPND 3 PROTEIN 1;
COMPND 4 CHAIN: A;
COMPND 5 SYNONYM: MALT LYMPHOMA-ASSOCIATED TRANSLOCATION, PARACASPASE;
COMPND 6 EC: 3.4.22.-;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MALT1, MLT;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR F.SCHLAUDERER,K.LAMMENS,K.P.HOPFNER
REVDAT 3 28-FEB-24 4I1R 1 REMARK SEQADV
REVDAT 2 16-OCT-13 4I1R 1 JRNL
REVDAT 1 28-AUG-13 4I1R 0
JRNL AUTH F.SCHLAUDERER,K.LAMMENS,D.NAGEL,M.VINCENDEAU,A.C.EITELHUBER,
JRNL AUTH 2 S.H.VERHELST,D.KLING,A.CHRUSCIEL,J.RULAND,D.KRAPPMANN,
JRNL AUTH 3 K.P.HOPFNER
JRNL TITL STRUCTURAL ANALYSIS OF PHENOTHIAZINE DERIVATIVES AS
JRNL TITL 2 ALLOSTERIC INHIBITORS OF THE MALT1 PARACASPASE.
JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 52 10384 2013
JRNL REFN ISSN 1433-7851
JRNL PMID 23946259
JRNL DOI 10.1002/ANIE.201304290
REMARK 2
REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.2
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.09
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 3 NUMBER OF REFLECTIONS : 10386
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.205
REMARK 3 R VALUE (WORKING SET) : 0.201
REMARK 3 FREE R VALUE : 0.249
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.820
REMARK 3 FREE R VALUE TEST SET COUNT : 1020
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 5
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.02
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2928
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2454
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2632
REMARK 3 BIN R VALUE (WORKING SET) : 0.2373
REMARK 3 BIN FREE R VALUE : 0.3179
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.11
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 296
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2803
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 25
REMARK 3 SOLVENT ATOMS : 26
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 86.51
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 105.1
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 6.40070
REMARK 3 B22 (A**2) : -11.77340
REMARK 3 B33 (A**2) : 5.37270
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 19.82370
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.510
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2884 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3894 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1034 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 76 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 401 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2884 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 365 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 3226 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 1.23
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.65
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 23.19
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|338 - A|720 }
REMARK 3 ORIGIN FOR THE GROUP (A): -21.3496 -17.6955 8.9455
REMARK 3 T TENSOR
REMARK 3 T11: -0.1141 T22: 0.0145
REMARK 3 T33: -0.1330 T12: 0.0862
REMARK 3 T13: -0.0839 T23: -0.0610
REMARK 3 L TENSOR
REMARK 3 L11: 3.2439 L22: 1.3351
REMARK 3 L33: 3.9010 L12: 1.4195
REMARK 3 L13: 2.7563 L23: 0.5081
REMARK 3 S TENSOR
REMARK 3 S11: 0.0573 S12: 0.0417 S13: 0.1411
REMARK 3 S21: -0.0406 S22: -0.0541 S23: 0.1228
REMARK 3 S31: -0.1108 S32: 0.0268 S33: -0.0032
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4I1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-12.
REMARK 100 THE DEPOSITION ID IS D_1000076194.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 23-JUN-12
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID29
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.972390
REMARK 200 MONOCHROMATOR : SI(111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 1667
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700
REMARK 200 RESOLUTION RANGE LOW (A) : 41.090
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.44
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 200 M MAGNESIUM FORMATE, 13 % PEG3350,
REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 47.41900
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.30400
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 47.41900
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.30400
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -3.64208
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 57.40959
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ARG A 467
REMARK 465 ASN A 468
REMARK 465 ASP A 469
REMARK 465 TYR A 470
REMARK 465 ASP A 471
REMARK 465 ASP A 472
REMARK 465 THR A 473
REMARK 465 ILE A 474
REMARK 465 PRO A 475
REMARK 465 ILE A 476
REMARK 465 LEU A 477
REMARK 465 ASP A 478
REMARK 465 ALA A 479
REMARK 465 LEU A 480
REMARK 465 LYS A 481
REMARK 465 VAL A 482
REMARK 465 GLU A 497
REMARK 465 ALA A 498
REMARK 465 PHE A 499
REMARK 465 GLU A 500
REMARK 465 ILE A 501
REMARK 465 GLN A 502
REMARK 465 HIS A 503
REMARK 465 GLY A 566
REMARK 465 THR A 567
REMARK 465 GLU A 568
REMARK 465 TYR A 569
REMARK 465 SER A 570
REMARK 465 ALA A 571
REMARK 465 GLU A 572
REMARK 465 HIS A 721
REMARK 465 HIS A 722
REMARK 465 HIS A 723
REMARK 465 HIS A 724
REMARK 465 HIS A 725
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 LYS A 341 CG CD CE NZ
REMARK 480 LYS A 358 CD CE NZ
REMARK 480 LYS A 360 CG CD CE NZ
REMARK 480 ARG A 374 CD NE CZ NH1 NH2
REMARK 480 LYS A 379 CE NZ
REMARK 480 LYS A 404 CG CD CE NZ
REMARK 480 PHE A 420 CG CD1 CD2 CE1 CE2 CZ
REMARK 480 LYS A 447 CB CG CD CE NZ
REMARK 480 GLU A 453 CG CD OE1 OE2
REMARK 480 LYS A 513 CG CD CE NZ
REMARK 480 LYS A 523 CG CD CE NZ
REMARK 480 LYS A 538 CD CE NZ
REMARK 480 LEU A 541 CG CD1 CD2
REMARK 480 LYS A 543 CG CD CE NZ
REMARK 480 GLN A 546 CG CD OE1 NE2
REMARK 480 LYS A 557 CG CD CE NZ
REMARK 480 ARG A 576 CD NE CZ NH1 NH2
REMARK 480 LYS A 582 CE NZ
REMARK 480 GLU A 585 CD OE1 OE2
REMARK 480 GLU A 588 CD OE1 OE2
REMARK 480 LYS A 593 CG CD CE NZ
REMARK 480 GLN A 599 CG CD OE1 NE2
REMARK 480 TYR A 620 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 480 LYS A 621 CG CD CE NZ
REMARK 480 ILE A 626 CG1 CG2 CD1
REMARK 480 MET A 627 CG SD CE
REMARK 480 TYR A 631 CE1 CE2 CZ OH
REMARK 480 LEU A 637 CB CG CD1 CD2
REMARK 480 LYS A 644 CG CD CE NZ
REMARK 480 TYR A 657 CD1 CE1 CE2 CZ OH
REMARK 480 LYS A 661 CG CD CE NZ
REMARK 480 LYS A 665 CG CD CE NZ
REMARK 480 LYS A 679 CG CD CE NZ
REMARK 480 GLN A 691 CG CD OE1 NE2
REMARK 480 GLU A 696 CG CD OE1 OE2
REMARK 480 LYS A 702 CG CD CE NZ
REMARK 480 LYS A 714 CD CE NZ
REMARK 480 HIS A 718 CE1 NE2
REMARK 480 ARG A 719 NE CZ NH1 NH2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 402 49.00 -69.53
REMARK 500 ASP A 462 76.31 -116.79
REMARK 500 SER A 660 -34.80 -39.63
REMARK 500 LEU A 711 -134.68 51.01
REMARK 500 ARG A 719 147.77 -171.05
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZU A 801
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4I1P RELATED DB: PDB
DBREF 4I1R A 339 719 UNP Q9UDY8 MALT1_HUMAN 339 719
SEQADV 4I1R MET A 338 UNP Q9UDY8 INITIATING METHIONINE
SEQADV 4I1R HIS A 720 UNP Q9UDY8 EXPRESSION TAG
SEQADV 4I1R HIS A 721 UNP Q9UDY8 EXPRESSION TAG
SEQADV 4I1R HIS A 722 UNP Q9UDY8 EXPRESSION TAG
SEQADV 4I1R HIS A 723 UNP Q9UDY8 EXPRESSION TAG
SEQADV 4I1R HIS A 724 UNP Q9UDY8 EXPRESSION TAG
SEQADV 4I1R HIS A 725 UNP Q9UDY8 EXPRESSION TAG
SEQRES 1 A 388 MET LEU ALA LYS ASP LYS VAL ALA LEU LEU ILE GLY ASN
SEQRES 2 A 388 MET ASN TYR ARG GLU HIS PRO LYS LEU LYS ALA PRO LEU
SEQRES 3 A 388 VAL ASP VAL TYR GLU LEU THR ASN LEU LEU ARG GLN LEU
SEQRES 4 A 388 ASP PHE LYS VAL VAL SER LEU LEU ASP LEU THR GLU TYR
SEQRES 5 A 388 GLU MET ARG ASN ALA VAL ASP GLU PHE LEU LEU LEU LEU
SEQRES 6 A 388 ASP LYS GLY VAL TYR GLY LEU LEU TYR TYR ALA GLY HIS
SEQRES 7 A 388 GLY TYR GLU ASN PHE GLY ASN SER PHE MET VAL PRO VAL
SEQRES 8 A 388 ASP ALA PRO ASN PRO TYR ARG SER GLU ASN CYS LEU CYS
SEQRES 9 A 388 VAL GLN ASN ILE LEU LYS LEU MET GLN GLU LYS GLU THR
SEQRES 10 A 388 GLY LEU ASN VAL PHE LEU LEU ASP MET CYS ARG LYS ARG
SEQRES 11 A 388 ASN ASP TYR ASP ASP THR ILE PRO ILE LEU ASP ALA LEU
SEQRES 12 A 388 LYS VAL THR ALA ASN ILE VAL PHE GLY TYR ALA THR CYS
SEQRES 13 A 388 GLN GLY ALA GLU ALA PHE GLU ILE GLN HIS SER GLY LEU
SEQRES 14 A 388 ALA ASN GLY ILE PHE MET LYS PHE LEU LYS ASP ARG LEU
SEQRES 15 A 388 LEU GLU ASP LYS LYS ILE THR VAL LEU LEU ASP GLU VAL
SEQRES 16 A 388 ALA GLU ASP MET GLY LYS CYS HIS LEU THR LYS GLY LYS
SEQRES 17 A 388 GLN ALA LEU GLU ILE ARG SER SER LEU SER GLU LYS ARG
SEQRES 18 A 388 ALA LEU THR ASP PRO ILE GLN GLY THR GLU TYR SER ALA
SEQRES 19 A 388 GLU SER LEU VAL ARG ASN LEU GLN TRP ALA LYS ALA HIS
SEQRES 20 A 388 GLU LEU PRO GLU SER MET CYS LEU LYS PHE ASP CYS GLY
SEQRES 21 A 388 VAL GLN ILE GLN LEU GLY PHE ALA ALA GLU PHE SER ASN
SEQRES 22 A 388 VAL MET ILE ILE TYR THR SER ILE VAL TYR LYS PRO PRO
SEQRES 23 A 388 GLU ILE ILE MET CYS ASP ALA TYR VAL THR ASP PHE PRO
SEQRES 24 A 388 LEU ASP LEU ASP ILE ASP PRO LYS ASP ALA ASN LYS GLY
SEQRES 25 A 388 THR PRO GLU GLU THR GLY SER TYR LEU VAL SER LYS ASP
SEQRES 26 A 388 LEU PRO LYS HIS CYS LEU TYR THR ARG LEU SER SER LEU
SEQRES 27 A 388 GLN LYS LEU LYS GLU HIS LEU VAL PHE THR VAL CYS LEU
SEQRES 28 A 388 SER TYR GLN TYR SER GLY LEU GLU ASP THR VAL GLU ASP
SEQRES 29 A 388 LYS GLN GLU VAL ASN VAL GLY LYS PRO LEU ILE ALA LYS
SEQRES 30 A 388 LEU ASP MET HIS ARG HIS HIS HIS HIS HIS HIS
HET LZU A 801 25
HETNAM LZU 10-{2-[(2S)-1-METHYLPIPERIDIN-2-YL]ETHYL}-2-
HETNAM 2 LZU (METHYLSULFANYL)-10H-PHENOTHIAZINE
HETSYN LZU THIORIDAZINE
FORMUL 2 LZU C21 H26 N2 S2
FORMUL 3 HOH *26(H2 O)
HELIX 1 1 ALA A 361 LEU A 376 1 16
HELIX 2 2 THR A 387 LEU A 401 1 15
HELIX 3 3 ARG A 435 CYS A 439 5 5
HELIX 4 4 VAL A 442 GLU A 451 1 10
HELIX 5 5 GLY A 509 LEU A 520 1 12
HELIX 6 6 LYS A 524 CYS A 539 1 16
HELIX 7 7 CYS A 539 LYS A 545 1 7
HELIX 8 8 LEU A 574 ALA A 583 1 10
HELIX 9 9 ASP A 642 ALA A 646 5 5
HELIX 10 10 THR A 650 THR A 654 5 5
HELIX 11 11 VAL A 659 LEU A 663 5 5
HELIX 12 12 PRO A 710 LYS A 714 5 5
SHEET 1 A 5 LYS A 379 LEU A 384 0
SHEET 2 A 5 LYS A 343 GLY A 349 1 N LEU A 347 O LEU A 383
SHEET 3 A 5 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348
SHEET 4 A 5 ASN A 422 MET A 425 -1 O PHE A 424 N TYR A 417
SHEET 5 A 5 LEU A 440 CYS A 441 -1 O LEU A 440 N MET A 425
SHEET 1 B 6 LYS A 379 LEU A 384 0
SHEET 2 B 6 LYS A 343 GLY A 349 1 N LEU A 347 O LEU A 383
SHEET 3 B 6 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348
SHEET 4 B 6 LEU A 456 CYS A 464 1 O VAL A 458 N LEU A 410
SHEET 5 B 6 ILE A 486 ALA A 491 1 O ALA A 491 N LEU A 461
SHEET 6 B 6 GLU A 549 SER A 552 -1 O ARG A 551 N PHE A 488
SHEET 1 C 4 MET A 590 LYS A 593 0
SHEET 2 C 4 GLN A 599 PHE A 608 -1 O LEU A 602 N MET A 590
SHEET 3 C 4 VAL A 611 TYR A 620 -1 O SER A 617 N GLN A 601
SHEET 4 C 4 LEU A 668 LEU A 672 -1 O LEU A 672 N MET A 612
SHEET 1 D 3 TYR A 631 THR A 633 0
SHEET 2 D 3 LEU A 682 CYS A 687 -1 O THR A 685 N THR A 633
SHEET 3 D 3 LYS A 702 GLY A 708 -1 O GLY A 708 N LEU A 682
CISPEP 1 ASN A 432 PRO A 433 0 2.41
CISPEP 2 THR A 654 GLY A 655 0 1.14
CISPEP 3 HIS A 718 ARG A 719 0 4.27
SITE 1 AC1 9 ALA A 345 LYS A 379 VAL A 381 ALA A 394
SITE 2 AC1 9 GLU A 397 LEU A 401 ARG A 576 TRP A 580
SITE 3 AC1 9 MET A 717
CRYST1 94.838 70.608 57.525 90.00 93.63 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010544 0.000000 0.000669 0.00000
SCALE2 0.000000 0.014163 0.000000 0.00000
SCALE3 0.000000 0.000000 0.017419 0.00000